Trials / Terminated
TerminatedNCT04619225
Cardiac Output and Recovery Time
Correlation Between Cardiac Output and Recovery Time After Reversal of Rocuronium-Induced Blockade With Sugammadex
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to determine the time it takes to reverse the effects of the intraoperative medication given to relax the muscles and how this period of recovery correlates with a function of the heart.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TetraGraph | FDA approved neuromuscular transmission monitor capable of measuring the depth of neuromuscular block in anesthetized patients who received neuromuscular blocking agents. TetraGraph uses EMG to measure the muscle action potentials that are generated in response to electrical neurostimulation via skin electrodes. |
Timeline
- Start date
- 2022-09-14
- Primary completion
- 2023-01-13
- Completion
- 2023-01-13
- First posted
- 2020-11-06
- Last updated
- 2026-02-04
- Results posted
- 2026-02-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04619225. Inclusion in this directory is not an endorsement.